Author

Mamiko Aoi

Observed name: Aoi Mamiko

Institution: Kansai Medical University

Observed institution: Kansai Medical University

ORCID: 0009-0007-0954-4599

Observed ORCID: 0009-0007-0954-4599

OpenAlex ID: A5004886849

Downregulation of MicroRNA-21 in Colonic CD3+ T Cells in UC Remission

2016 · Yugo Ando, Luca Mazzurana, et al. · Inflammatory Bowel Diseases · 33

Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice

2022 · Masataka Masuda, Norimasa Fukata, et al. · JGH Open · 14

Establishment of a Novel Colitis-Associated Cancer Mouse Model Showing Flat Invasive Neoplasia

2022 · Tomio Uragami, Yugo Ando, et al. · Digestive Diseases and Sciences · 7

Combined serum albumin, fecal immunochemical test, and leucine-rich alpha-2 glycoprotein levels for predicting prognosis in remitting patients with ulcerative colitis

2023 · Naohiro Nakamura, Yusuke Honzawa, et al. · Scientific Reports · 6

Leucine-rich alpha-2 glycoprotein is useful in predicting clinical relapse in patients with Crohn’s disease during biological remission

2024 · Naohiro Nakamura, Yusuke Honzawa, et al. · Intestinal Research · 3

Diagnostic accuracy of endoscopic findings for cytomegalovirus reactivation in hospitalized patients with ulcerative colitis

2026 · Mamiko Aoi, Naohiro Nakamura, et al. · PLoS ONE · 1

Establishment of a Novel Colitis-Associated Cancer Mouse Model Showing Flat Invasive Neoplasia

2023 · Uragami Tomio, Ando Yugo, et al. · Institutional Repositories DataBase (IRDB)

Analysis of the initial dose and reduction rate of corticosteroid for ulcerative colitis in clinical practice

2022 · Masuda Masataka, Fukata Norimasa, et al. · Institutional Repositories DataBase (IRDB)

Works count: 8

Citation count: 64

H-index: 4

I10-index: 2